--- title: "Nexalin Acquires AI Health Platform Ahead Of HALO Clarity Pivotal Trial" type: "News" locale: "en" url: "https://longbridge.com/en/news/286923106.md" description: "Nexalin Technology Inc. (NXL) has acquired PONM Inc. from GreenLight Ventures for $1.3 million, enhancing its HALO Clarity program with AI-integrated remote patient monitoring and virtual clinic management tools. This acquisition supports Nexalin's pivotal trial for moderate-to-severe insomnia, expected to begin in Q2 2026. GreenLight Ventures becomes a significant equity holder and strategic partner, aiding in product and regulatory support. Nexalin's stock closed at $0.32, down 5.26%." datetime: "2026-05-19T13:35:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286923106.md) - [en](https://longbridge.com/en/news/286923106.md) - [zh-HK](https://longbridge.com/zh-HK/news/286923106.md) --- # Nexalin Acquires AI Health Platform Ahead Of HALO Clarity Pivotal Trial (RTTNews) - Nexalin Technology Inc. (NXL), a developer of non-invasive neurostimulation devices, announced the acquisition of PONM Inc. from GreenLight Ventures. PONM is the digital health platform supporting Nexalin's HALO Clarity program and Nexalin NeuroCare virtual clinic. The acquisition gives Nexalin ownership of AI-integrated remote patient monitoring, treatment-compliance data capture, electronic health record functionality, and virtual-clinic management tools. The platform is already deployed at the University of California, San Diego, where it supports HALO headset usage tracking, physician oversight and clinical research workflows. Nexalin stated that the integrated device-plus-software model is central to its planned pivotal trial of HALO Clarity for moderate-to-severe insomnia, with enrolment expected to begin in Q2 2026. The platform is designed to strengthen treatment oversight, improve protocol adherence, and provide scalable infrastructure for physician-supervised, at-home neurostimulation programs. As part of the transaction, GreenLight Ventures, LLC became a significant equity holder in Nexalin and entered into a strategic partnership to provide ongoing product, engineering, regulatory, and commercial support. Nexalin emphasized that the deal aligns both parties around the long-term success of HALO Clarity and its broader neurostimulation platform. Total consideration for the acquisition is $1.3 million, payable in shares of Nexalin common stock issued in tranches over time at prices tied to market performance. Nexalin's CEO Mark White said the transaction strengthens the company's control over the HALO Clarity ecosystem by combining device, software, and AI-enabled data infrastructure under one platform. He noted that this integration is expected to support pivotal trial execution, regulatory submission, and potential commercial launch. NXL has traded between $0.31 and $2.00 over the past year. The stock closed Monday's trading at $0.32, down 5.26%. In pre-market trading the stock is at $0.31, down 1.94%. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. ### Related Stocks - [NXL.US](https://longbridge.com/en/quote/NXL.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md) - [NXLIW.US](https://longbridge.com/en/quote/NXLIW.US.md) ## Related News & Research - [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md) - [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md) - [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md) - [BUZZ-Dexcom to add two directors in deal with activist Elliott; shares up](https://longbridge.com/en/news/286465778.md) - [Northwestern Mutual Wealth Management Co. Acquires 186,584 Shares of Danaher Corporation $DHR](https://longbridge.com/en/news/286744959.md)